📰 Naomi Eichenbaum News
Naomi Eichenbaum News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Naomi Eichenbaum. Real-time updates on events, politics, business and more.
November 10, 2023
Operator: Good day, and welcome to the Travere Therapeutics Third Quarter 2023 Financial Results and Corporate Update Conference Call. Todays conference call is being recorded.
November 7, 2023
Received 430 new patient start forms for FILSPARI® in the third quarter of 2023; demand and payer coverage continued to grow Net product sales of FILSPARI...
November 3, 2023
Two-year results from both PROTECT and DUPLEX pivotal Phase 3 studies demonstrate treatment with sparsentan has the potential to preserve kidney function and significantly delay time to kidney...
October 11, 2023
SAN DIEGO, Oct. 11, 2023 -- Travere Therapeutics, Inc. today announced that on October 10, 2023, the Compensation Committee of its Board of Directors granted inducement equity grants to nine new...
September 27, 2023
SAN DIEGO, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that the Company and its collaborators will present preliminary findings from the SPARTAN Study evaluating
September 26, 2023
SAN DIEGO, Sept. 26, 2023 -- Travere Therapeutics, Inc. today announced that the Company and its collaborators will present preliminary findings from the SPARTAN Study evaluating the potential...
September 21, 2023
FILSPARI® achieved a clinically meaningful difference vs. irbesartan in eGFR total slope [p= 0.058] and eGFR chronic slope [p=0.037]. Patients treated with FILSPARI over two years exhibited one of...
August 31, 2023
SAN DIEGO, Aug. 31, 2023 -- Travere Therapeutics, Inc. today announced that company management will present at the 2023 Wells Fargo Healthcare Conference on Thursday, September 7, 2023, at 10:15...
August 24, 2023
SAN DIEGO, Aug. 24, 2023 -- Travere Therapeutics, Inc. today announced that the Company will present clinical data from the Phase 1/2 COMPOSE Study of pegtibatinase, a novel investigational enzyme...
August 8, 2023
Travere Therapeutics, Inc. (NASDAQ:TVTX) Q2 2023 Earnings Call Transcript August 4, 2023 Operator: Good day, and welcome to the Travere Therapeutics Second Quarter 2023 Financial Results and Corporate Update Conference Call. Today’s conference call is being recorded. At this time, I would like to turn the conference call over to the Vice President of Investor […]